0 CHECKOUT

Mitsubishi Tanabe Pharma Corporation - SWOT, Strategy and Corporate Finance Report

  • ID: 2260774
  • May 2013
  • 63 pages
  • MarketLine

Mitsubishi Tanabe Pharma Corporation - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360° view of the company.

Features:

- Detailed information on Mitsubishi Tanabe Pharma Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Mitsubishi Tanabe Pharma Corporation in the form of a SWOT analysis
- An in-depth view of the business model of Mitsubishi Tanabe Pharma Corporation including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Mitsubishi Tanabe Pharma Corporation
- Intelligence on Mitsubishi Tanabe Pharma Corporationnv’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Mitsubishi READ MORE >

Note: Product cover images may vary from those shown

Company Snapshot
Mitsubishi Tanabe Pharma Corporation: Company Overview
Mitsubishi Tanabe Pharma Corporation: Overview and Key Facts

Mitsubishi Tanabe Pharma Corporation: Overview

Mitsubishi Tanabe Pharma Corporation: Key Facts
Mitsubishi Tanabe Pharma Corporation: Key Employees
Mitsubishi Tanabe Pharma Corporation: Major Products and Services
Mitsubishi Tanabe Pharma Corporation: Company History
Mitsubishi Tanabe Pharma Corporation: Management Statement
Mitsubishi Tanabe Pharma Corporation: Locations and Subsidiaries
Mitsubishi Tanabe Pharma Corporation: Key Competitors
Mitsubishi Tanabe Pharma Corporation: Company Analysis
Mitsubishi Tanabe Pharma Corporation: Business Description
Mitsubishi Tanabe Pharma Corporation: SWOT Analysis

Mitsubishi Tanabe Pharma Corporation: SWOT Overview

Mitsubishi Tanabe Pharma Corporation: Strengths

Mitsubishi Tanabe Pharma Corporation: Weaknesses

Mitsubishi Tanabe Pharma Corporation: Opportunities

Mitsubishi Tanabe Pharma Corporation: Threats
Mitsubishi Tanabe Pharma Corporation: Financial Analysis

Mitsubishi Tanabe Pharma Corporation: Financial Overview

Mitsubishi Tanabe Pharma Corporation: Five Year Company Financials

Mitsubishi Tanabe Pharma Corporation: Key Income Statement Data

Mitsubishi Tanabe Pharma Corporation: Key Balance Sheet Data

Mitsubishi Tanabe Pharma Corporation: Key Cash Flow Data

Mitsubishi Tanabe Pharma Corporation: Key Market Data

Mitsubishi Tanabe Pharma Corporation: Valuation Ratios

Mitsubishi Tanabe Pharma Corporation: Profitability Ratios

Mitsubishi Tanabe Pharma Corporation: Management Efficiency Ratios

Mitsubishi Tanabe Pharma Corporation: Financial Strength Ratios

Mitsubishi Tanabe Pharma Corporation: Operational Efficiency Ratios

Mitsubishi Tanabe Pharma Corporation: Others
Mitsubishi Tanabe Pharma Corporation: Corporate Financial Deals Activity
Mitsubishi Tanabe Pharma Corporation: Financial Deals Overview
Mitsubishi Tanabe Pharma Corporation: Targets and Partners
Mitsubishi Tanabe Pharma Corporation: Top Deals 2009 - 2013YTD-
Mitsubishi Tanabe Pharma Corporation: Corporate Venturing
Mitsubishi Tanabe Pharma Corporation: Partnership
Mitsubishi Tanabe Pharma Corporation: Divestments
Mitsubishi Tanabe Pharma Corporation: Recent Developments
Mitsubishi Tanabe Pharma Corporation: News and Events Summary
Mitsubishi Tanabe Pharma Corporation: Business Expansion
Mitsubishi Tanabe Pharma Corporation: Business Reorganization
Mitsubishi Tanabe Pharma Corporation: Contracts
Mitsubishi Tanabe Pharma Corporation: Financial Deals
Mitsubishi Tanabe Pharma Corporation: Financial Performance
Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events
Mitsubishi Tanabe Pharma Corporation: Research & Development
Mitsubishi Tanabe Pharma Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions

List of Tables

Table 1: Mitsubishi Tanabe Pharma Corporation: Key Facts
Table 2: Mitsubishi Tanabe Pharma Corporation: Key Employees
Table 4: Mitsubishi Tanabe Pharma Corporation: Key Competitors
Table 5: Mitsubishi Tanabe Pharma Corporation: Key Income Statement Data
Table 6: Mitsubishi Tanabe Pharma Corporation: Key Balance Sheet Data
Table 7: Mitsubishi Tanabe Pharma Corporation: Key Cash Flow Data
Table 8: Mitsubishi Tanabe Pharma Corporation: Key Market Data
Table 9: Mitsubishi Tanabe Pharma Corporation: Key Growth Ratios
Table 10: Mitsubishi Tanabe Pharma Corporation: Valuation Ratios
Table 11: Mitsubishi Tanabe Pharma Corporation: Profitability Ratios
Table 12: Mitsubishi Tanabe Pharma Corporation: Management Efficiency Ratios
Table 13: Mitsubishi Tanabe Pharma Corporation: Financial Strength Ratios
Table 14: Mitsubishi Tanabe Pharma Corporation: Operational Efficiency Ratios
Table 15: Mitsubishi Tanabe Pharma Corporation: Others
Table 16: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (TTM-)
Table 17: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (2009 - YTD-2013)
Table 18: Mitsubishi Tanabe Pharma Corporation: Targets and Partners
Table 19: Mitsubishi Tanabe Pharma Corporation: Top Deals 2009 - 2013YTD-
Table 20: Mitsubishi Tanabe Pharma Corporation: Corporate Venturing Volume and Value Trend (2009 - YTD-2013)
Table 21: Mitsubishi Tanabe Pharma Corporation: Corporate Venturing by Geography (2009 - YTD-2013)
Table 22: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2009 - YTD-2013)
Table 23: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2009 - YTD-2013)
Table 24: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2009 - YTD-2013)
Table 25: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2009 - YTD-2013)
Table 26: Mitsubishi Tanabe Pharma Corporation: News and Events Summary
Table 27: Mitsubishi Tanabe Pharma Corporation: Business Expansion
Table 28: Mitsubishi Tanabe Pharma Corporation: Business Reorganization
Table 29: Mitsubishi Tanabe Pharma Corporation: Contracts
Table 30: Mitsubishi Tanabe Pharma Corporation: Financial Deals
Table 31: Mitsubishi Tanabe Pharma Corporation: Financial Performance
Table 32: Mitsubishi Tanabe Pharma Corporation: Regulatory and Legal Events
Table 33: Mitsubishi Tanabe Pharma Corporation: Research & Development
Table 34: Mitsubishi Tanabe Pharma Corporation: Strategy and Operations

List of Figures

Figure 1: Mitsubishi Tanabe Pharma Corporation: Revenue to Net Income (2007-2011)
Figure 2: Mitsubishi Tanabe Pharma Corporation: Revenue/Employee to Net Income/Employee (2007-2011)
Figure 3: Mitsubishi Tanabe Pharma Corporation: Current Assets to Current Liabilities (2007-2011)
Figure 4: Mitsubishi Tanabe Pharma Corporation: Assets, Liabilities to Total Equity (2007-2011)
Figure 5: Mitsubishi Tanabe Pharma Corporation: Free Cash Flow to Cash from Operating Activities (2007-2011)
Figure 6: Mitsubishi Tanabe Pharma Corporation: Net Change in Cash (2007-2011)
Figure 7: Mitsubishi Tanabe Pharma Corporation: Market Capitalization to Year-end Share Price (2007-2011)
Figure 8: Mitsubishi Tanabe Pharma Corporation: Enterprise Value (2007-2011)
Figure 9: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (TTM-)
Figure 10: Mitsubishi Tanabe Pharma Corporation: Deal Activity by Deal Type - Volume (2009 - YTD-2013)
Figure 11: Mitsubishi Tanabe Pharma Corporation: Corporate Venturing Volume and Value Trend (2009 - YTD-2013)
Figure 12: Mitsubishi Tanabe Pharma Corporation: Corporate Venturing by Geography (2009 - YTD-2013)
Figure 13: Mitsubishi Tanabe Pharma Corporation: Partnership Volume and Value Trend (2009 - YTD-2013)
Figure 14: Mitsubishi Tanabe Pharma Corporation: Partnership Trend by Deal Type (2009 - YTD-2013)
Figure 15: Mitsubishi Tanabe Pharma Corporation: Divestments Volume and Value Trend (2009 - YTD-2013)
Figure 16: Mitsubishi Tanabe Pharma Corporation: Divestments by Geography (2009 - YTD-2013)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • UBS AG
  • RBC Capital Markets
  • Credit Suisse Group
  • J.P. Morgan & Co.
  • Deloitte LLP.